ArticleNature communications2023
Synthetic control of correlated disorder in UiO-66 frameworks.
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Multitopic acid modulation unlocks a new dimensionality in defect-engineered MOFs.Chemical science · 2026Article
- Interfacial Lewis Acid Chemistry Enabled by Mesoporous MOFs Toward High-Performance Four-Electron Zinc-Iodine Batteries.Angewandte Chemie (International ed. in English) · 2026Article
- Solvent-Free Thermal Defect Engineering in Molecular Frameworks With Volatile Linkers.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Defect-Guided Assembly of Aperiodic and Flexible Metal-Organic Frameworks From Pre-Formed Cages.Angewandte Chemie (International ed. in English) · 2026Article
- Interplay of defects and dopants inRSC advances · 2026Article
- Retrospective Review on Reticular Materials: Facts and Figures Over the Last 30 Years.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Fingerprinting Single and Clustered Cu Sites in Metalated MOF Catalysts via TD-DFT and In Situ Diffuse Reflectance UV-Vis Spectroscopy.ACS applied materials & interfaces · 2025Article
- Review
- Clickable Polymer-Based Coatings for Modulating the Interaction of Metal-Organic Framework Nanocrystals with Living Cells.ACS applied materials & interfaces · 2025Article
- A lanthanide MOF with nanostructured node disorder.Nature communications · 2025Article
- Ultrafast synthesis of zirconium-porphyrin framework nanocrystals from alkoxide precursors.Cell reports. Physical science · 2024Article
- UiO-66 with Both Brønsted and Lewis Acid Sites for Catalytic Synthesis of Biodiesel.Molecules (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Changing the perception of defects as imperfections in crystalline frameworks into correlated domains amenable to chemical control and targeted design might offer opportunities for the design of porous materials with superior performance or distinctive behavior in catalysis, separation, storage, or guest recognition. From a chemical standpoint, the establishment of synthetic protocols adapted to control the generation and growth of correlated disorder is crucial to consider defect engineering a practicable route towards adjusting framework function. By using UiO-66 as experimental platform, we systematically explored the framework chemical space of the corresponding defective materials. Periodic disorder arising from controlled generation and growth of missing cluster vacancies can be chemically controlled by the relative concentration of linker and modulator, which has been used to isolate a crystallographically pure "disordered" reo phase. Cs-corrected scanning transmission electron microscopy is used to proof the coexistence of correlated domains of missing linker and cluster vacancies, whose relative sizes are fixed by the linker concentration. The relative distribution of correlated disorder in the porosity and catalytic activity of the material reveals that, contrarily to the common belief, surpassing a certain defect concentration threshold can have a detrimental effect.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.